Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Sun Pharmaceutical Industries Ltd.
483
•Sun Pharmaceutical Industries Ltd.•June 13, 2025

Sun Pharmaceutical Industries Ltd. – FDA 483, Jun 13, 2025

Record Details

Sun Pharmaceutical Industries Ltd., located in Halol, Gujarat, India, underwent an FDA inspection from June 2 to June 13, 2025. The inspection revealed significant violations concerning the prevention of microbiological contamination in sterile drug products. Key issues included inadequate aseptic procedures and poor environmental monitoring, which were repeat observations from a previous warning letter issued in December 2022.

Specific violations observed during the inspection included improper handling and disinfection of equipment and materials within sterile environments. For instance, operators were observed transferring items into sterile areas without proper disinfection, and there were instances of personnel reaching over open sterile containers, risking contamination. Additionally, space constraints led to compromised aseptic techniques, such as operators having to reach over sterile areas, and inadequate airflow studies for exposed materials.

The regulatory framework requires drug manufacturers to adhere to stringent aseptic processing standards to ensure product sterility. The FDA's observations indicate non-compliance with these standards, necessitating immediate corrective actions. Sun Pharmaceutical Industries Ltd. is expected to address these deficiencies by revising their aseptic procedures, enhancing environmental monitoring, and ensuring adequate personnel training to prevent future occurrences. The company is encouraged to discuss any objections or corrective actions with the FDA or submit detailed plans to rectify the identified issues.

Company
Sun Pharmaceutical Industries Ltd.
Inspection date
June 13, 2025
Product type
Drugs
Office
Baltimore District Office
People
  • Pratik S. Upadhyay
  • Lisa L. Flores (Consumer Safety Officer/ Federal Investigator)
  • Justin A. Boyd (Research Specialist II)
View Company Profile

ID · 5ed2e773-718b-4c81-a604-202e4fe991ea

Violation Codes2
None21 CFR 211.192

Full citation text and observation details available on the Dashboard.

Other documents for Sun Pharmaceutical Industries Ltd.
  • 483 - 2022-05-09May 9, 2022
  • 483 - 2019-12-13December 13, 2019
  • 483 - 2019-06-11June 11, 2019
  • EIR - 2019-06-11June 11, 2019
  • 483 - 2018-08-31August 31, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sun Pharmaceutical Industries Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.